|
VPS28 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.372320E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.745900E-02 |
| Normal-vs-Stage2 |
7.422400E-02 |
| Normal-vs-Stage3 |
6.773500E-02 |
| Normal-vs-Stage4 |
1.561010E-01 |
| Stage1-vs-Stage2 |
3.652000E-01 |
| Stage1-vs-Stage3 |
6.825800E-01 |
| Stage1-vs-Stage4 |
9.162800E-01 |
| Stage2-vs-Stage3 |
6.163800E-01 |
| Stage2-vs-Stage4 |
5.151600E-01 |
| Stage3-vs-Stage4 |
8.300000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.022590E-01 |
| Normal-vs-AfricanAmerican |
3.428000E-04 |
| Normal-vs-Asian |
8.974300E-02 |
| Caucasian-vs-AfricanAmerican |
4.403800E-04 |
| Caucasian-vs-Asian |
1.283620E-01 |
| AfricanAmerican-vs-Asian |
9.428600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.146400E-02 |
| Normal-vs-Female |
9.759400E-03 |
| Male-vs-Female |
3.920600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.134400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.491800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.862000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.537900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.449600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.370400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.853400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.373400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.457970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.229790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.902390E-02 |
| Normal-vs-Grade 2 |
4.255600E-02 |
| Normal-vs-Grade 3 |
3.389600E-02 |
| Normal-vs-Grade 4 |
1.868370E-01 |
| Grade 1-vs-Grade 2 |
4.591000E-01 |
| Grade 1-vs-Grade 3 |
4.058200E-01 |
| Grade 1-vs-Grade 4 |
3.653800E-01 |
| Grade 2-vs-Grade 3 |
9.870400E-01 |
| Grade 2-vs-Grade 4 |
9.889600E-01 |
| Grade 3-vs-Grade 4 |
9.977000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.081810E-01 |
| Normal-vs-ccB subtype |
8.526200E-01 |
| ccA subtype-vs-ccB subtype |
8.800300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.385400E-01 |
| Normal-vs-N1 |
1.332770E-01 |
| N0-vs-N1 |
2.111000E-01 |
|
|
